Skip to Main Content
Table 3—

Medical management changes at most recent visit

Patients with medication changesPatients with medication initiationP value
Changes in therapy among patients with elevated HbA1c    
    HbA1c threshold   0.002 
        >7.0% 40.4% (440/1,088)   
        >8.0% 45.6% (317/695)   
        >9.0% 48.5% (199/410)   
Medication initiation among untreated patients with elevated blood pressure    
    Blood pressure threshold   0.3 
        >130/80 mmHg  10.1% (21/208)  
        >140/90 mmHg  15.1% (14/93)  
        >150/100 mmHg  13.9% (5/36)  
Medication initiation among untreated patients with elevated LDL cholesterol    
    LDL cholesterol threshold   0.005 
        >100 mg/dl  5.6% (24/427)  
        >130 mg/dl  8.7% (16/185)  
        >160 mg/dl  15.4% (10/65)  
Patients with medication changesPatients with medication initiationP value
Changes in therapy among patients with elevated HbA1c    
    HbA1c threshold   0.002 
        >7.0% 40.4% (440/1,088)   
        >8.0% 45.6% (317/695)   
        >9.0% 48.5% (199/410)   
Medication initiation among untreated patients with elevated blood pressure    
    Blood pressure threshold   0.3 
        >130/80 mmHg  10.1% (21/208)  
        >140/90 mmHg  15.1% (14/93)  
        >150/100 mmHg  13.9% (5/36)  
Medication initiation among untreated patients with elevated LDL cholesterol    
    LDL cholesterol threshold   0.005 
        >100 mg/dl  5.6% (24/427)  
        >130 mg/dl  8.7% (16/185)  
        >160 mg/dl  15.4% (10/65)  

Percentages of patients at each risk factor threshold are not mutually exclusive. P values are derived from the Mantel-Haenszel test for trend.

Close Modal

or Create an Account

Close Modal
Close Modal